GeoVax Labs, Inc. (GOVX)
0.374
-0.01
(-3.53%)
USD |
NASDAQ |
Dec 12, 16:00
0.374
0.00 (0.00%)
After-Hours: 16:10
GeoVax Labs Research and Development Expense (TTM): 22.74M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Omeros Corp. | 84.14M |
| Tonix Pharmaceuticals Holding Corp. | 35.84M |
| Vistagen Therapeutics, Inc. | 49.02M |
| Daré Bioscience, Inc. | 6.616M |
| Jaguar Health, Inc. | 15.19M |